Crane Rosemary A
SEC-identified person · CIK 1443343 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Teva Pharmaceutical Industries LTD TEVA | Director | filed 2018–2026 |
| Certara, Inc. CERT | Director | filed 2022–2026 |
| Tarsus Pharmaceuticals, Inc. TARS | Director | filed 2021–2024 |
| Catalent, Inc. CTLT | Director | filed 2018–2023 |
| PDS Biotechnology Corp PDSB | Director | filed 2017–2019 |
| Unilife Corp UNIS | Director | filed 2016–2016 |
| Strata Skin Sciences, Inc. SSKN | Director · CEO and President | filed 2013–2014 |
| Epocrates INC EPOC | Director · President and CEO | filed 2011–2011 |
| Targanta Therapeutics Corp. TARG | Director | filed 2008–2008 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.